SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-014297
Filing Date
2019-04-30
Accepted
2019-04-30 16:18:20
Documents
7
Period of Report
2019-06-18
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A scph-def14a_20190430.htm DEF 14A 844716
2 GRAPHIC g1xi1svgmj1g000002.jpg GRAPHIC 4042
3 GRAPHIC g1xi1svgmj1g000006.jpg GRAPHIC 46294
4 GRAPHIC g1xi1svgmj1g000004.jpg GRAPHIC 4518
5 GRAPHIC g1xi1svgmj1g000005.jpg GRAPHIC 54118
6 GRAPHIC g1xi1svgmj1g000003.jpg GRAPHIC 4518
7 GRAPHIC g1xi1svgmj1g000001.jpg GRAPHIC 4518
  Complete submission text file 0001564590-19-014297.txt   1009176
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38293 | Film No.: 19782004
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1